Skip to main content
Tuesday
December 05, 2023
Sign In
Subscribe
Home
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
World+Biz
Sports
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Epaper
GOVT. Ad
More
Subscribe
Videos
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
COVID-19
Long Read
Interviews
Offbeat
Tech
Magazine
বাংলা
TUESDAY,
DECEMBER 05, 2023
Bharat Biotech Covid-19 vaccine
Coronavirus chronicle
India gives nod to Bharat Biotech for intranasal Covid booster doses
The trials will be held at nice different sites
Coronavirus chronicle
WHO issues emergency use listing for COVAXIN Covid-19 jab
Coronavirus chronicle
India recommends homemade Covid-19 vaccine for kids aged 2 and above
Coronavirus chronicle
India to miss end-July vaccination target as Bharat Biotech lags
Coronavirus chronicle
India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract
Coronavirus chronicle
Brazil official warned Bolsonaro over pressure to buy Bharat vaccine
Coronavirus chronicle
Covaxin 77.8% effective in phase 3 trial data
Coronavirus chronicle
FDA rejects emergency use authorization of Bharat Biotech’s Covaxin jab
Coronavirus chronicle
Covaxin’s US approval delayed over data, Bharat Biotech’s partner to file for full approval
Coronavirus chronicle
Bharat Biotech submits ‘90% of documents’ for WHO nod
Coronavirus chronicle
Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states
Coronavirus chronicle
Narendra Modi gets second dose of Covid vaccine
Coronavirus chronicle
India's drug regulator panel eases use condition for home-grown vaccine
Show More